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The rationale of this research was to prepare a gastroretentive drug delivery 
system of Ranitidine HCL. Floating Drug delivery system used to target drug 
release in the stomach or to the upper part of the intestine. The oral delivery 
of Ranitidine is tested by preparing a non-disintegrating floating dosage form, 
which increase its absorption in the stomach by increasing the drug’s gastric 
residence time. The polymer PVC and Sodium bicarbonate was used as the 
gas–generating agents. Sodium bicarbonate causes the tablets to floats for 
more then 24hr. The prepared tablets were evaluated on their 
physicochemical properties and drug release characters. In-vitro release 
studies indicate that the Ranitidine release form the floating dosage form was 
uniform followed zero order release. A combination of sodium bicarbonate 
(70mg) and citric acid (15mg) was found to achieve Optimum in vitro 
buoyancy. The tablets with methocel K100 were found to float for longer 
duration of time as compared to formulations containing methocel K15M. 
The drug release from the tablets was sufficiently sustained. 
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Introduction  
Ranitidine (C13H22N4O3S) is a histamine H2-receptor 
antagonist. It is extensively given in gastric ulcers, 
duodenal ulcers, and Zollinger-Ellison disease and 
gastro esophageal reflux disease [1]. The suggested 
adult oral dosage of ranitidine is 150 mg twice daily or 
300 mg once daily. The effective treatment of erosive 
esophagitis requires administration of 150 mg of 
ranitidine 4 times a day [2]. For the short term 
symptomatic relief of heartburn or non-ulcer dyspepsia 
a dose of 120 mg up to twice daily is suggested [3]. The 
short biological half-life of the drug (2.0-3.5 hrs) also 
favors growth of a sustained-release formulation [4]. A 
conventional oral sustained-release formulation 
releases  most  of  the  drug  at the colon; thus, the drug  
 
should have an absorption window either in the colon 
or throughout the gastrointestinal tract. Ranitidine is 
absorbed in only the initial part of the small intestine 
and has 50% absolute bioavailability [5]. Colonic 
metabolism of ranitidine is partly responsible for the 
poor bioavailability of ranitidine from the colon [6]. It 
has been reported that the oral action of gastric 
disorders with an H2 receptor antagonist like ranitidine 
or famotidine used in grouping with antacids promotes 
local delivery of these drugs to the receptor of parietal 
cell wall. Local delivery also increases the stomach cell 
wall receptor site bioavailability and increases efficacy 
of drugs to reduce acid secretion [7].  Therefore this 
attitude could be useful for humanizing systemic as 
well as local delivery of Ranitidine, which would 
efficiently reduced gastric acid secretion [8]. 
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In the current research on floating tablets of ranitidine 
HCL were prepared by effervescent approach using 
two different grades of methocel these are as follow :- 
• Methocel K100 and 
• Methocel K15M. 
The aim of the work was to evaluate the effect of gel-
forming polymer methocil on floating property and 
release individuality of ranitidine tablets. 
 
Materials and methods 
Materials 
Ranitidine was received as a gift sample from 
Mundipharma Pvt. Ltd. Delhi, India Methocel K100 
(100 cPs apparent viscosity as a 2% solution) and 
methocel K15M (15,000 cPs apparent viscosity as a 
2% solution) were received as gift samples from 
Colorcon Asia Pvt. Ltd., Goa, India. Magnesium 
stearate and hydrochloric acid were received as a gift 
sample from Torrent Research Centre (Ahemdabad 
India), Sodium bicarbonate, citric acid anhydrous, 
Lactose and purified talc were receive as a gift sample 
from Aristo Pharma Pvt. Ltd. Bhopal, India, Polyvinyl 
pyrrolidone K-30 (PVP K-30) was procured from S.D. 
Fine-Chem., Ahmedabad, India. All other ingredients 
were of the laboratory grade. 
 
Methods 
Preparation of floating tablets of ranitidine 
The concentration of different ingredients of Ranitidine 
floating tablets which was used, shown in table 1. The 
ingredients were weighed accurately and mixed 
thoroughly. Granulation of ranitidine were prepared 
with a solution of PVP K-30 in adequate amount of  
isopropyl alcohol as a solvent .The granules  were pass 
through 40 mesh size sieve and then dried in 
conservative hot air oven at about 40-50 °C, after few 
time drying of the granules was stopped. The loss on 
drying (LOD) value of dried granules was obtained 
between ranging from  1.5 to 3.5 %, by help of  
moisture balance at 100 ± 05°C for 10 min.Then dried 
granules were again sized through 40-60 mesh and 
lubricated with magnesium stearate (0.8% w/w) and 
purified talc (0.8%w/w) and then compressed on a 
single punch tablet machine (Cadmach  single press 
Choukase Lab. Indore, India). The tablets were round 
and flat in shape with an average diameter of 11.5 ± 0.2 
mm and a thickness of 3.1 ± 0.2 mm size. 
 
Table 1. Composition of floating tablets of ranitidine (B = batch number). 
 
Ingredients 
(in mg per 
tablet) 
B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 
Ranitidine 120 120 120 120 120 120 120 120 120 120 
Methocel 
K100 
     75 65 60 55 50 
Methocel 
K15M 
75 65 60 55 50      
Sodium 
bicarbonate 
70 70 70 70 70 70 70 70 70 70 
Citric acid 20 15 15 10 10 20 15 15 10 10 
PVP K-30 40 40 40 40 40 40 40 40 40 40 
Lactose 80 80 80 80 80 80 80 80 80 80 
 
Evaluation of granules 
Flow properties of granules 
The flow properties of granules were evaluated in 
terms of angle of repose, Carr index and Hausner ratio. 
For  determination  of  angle  of repose (θ) the granules  
 
were poured through the walls of a funnel, which was 
set at a place such that its lower tip was at a height of 
closely 2.0 cm above from ground surface. The 
granules were poured up to the time when upper tip of 
the pile surface touched the lower tip of the funnel. The 
tan¯1 of (height of the pile / radius of its base) give the 
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angle of repose. Granules were poured gently through a 
glass funnel into a graduated cylinder cut exactly to 10 
ml mark. Excess granules were removed using a 
spatula and the weight of the cylinder with pellets 
required for filling the cylinder volume was calculated. 
The cylinder was then tapped from a height of 2.0cm 
until the time when there was no more decrease in the 
volume. Bulk density (ρb) and tapped density (ρt) were 
calculated. Hausner ratio (HR) and Carr index (IC) 
were calculated according to the two equations which 
are follows:- 
                    HR= ρb / ρt 
                    IC = ρt- ρb/ ρt 
 
Evaluation of floating tablets 
The prepared floating tablets were evaluated for 
uniformity of weight using 20 tablets hardness test, by 
using Monsanto tester, friability using 10 tablets by 
Roche type friabilator at 100 rpm for 4min , and 
completed drug content, in vitro buoyancy and in vitro 
dissolution studies. The in-vitro buoyancy was 
determined by floating lag time, per the method 
accordingly Rosa et al. [9] the tablets were placed in a 
100 ml capacity beaker which contains 0.1N 
hydrochloric acid. The time required for the tablet to 
rise to the surface and float was determined as floating 
lag time. The duration of time the dosage form 
constantly remained on the surface of medium was 
determined as the total floating time [10]. 
The release rate of ranitidine from floating tablets was 
determined using United States Pharmacopoeia (USP) 
Dissolution Testing Apparatus 2 paddle method; 
(Choukase laboratory Indore India). The dissolution 
test was performed using 900 ml of 0.1N hydrochloric 
acid, at 37 ± 0.5°C and 50 rpm. A sample (10 ml) of 
the solution was withdrawn from the dissolution 
apparatus hourly and the samples were replaced with 
fresh dissolution medium. The samples were filtered 
through a 0.45μ membrane filter and diluted to a 
suitable concentration with 0.1N hydrochloric acid. 
Absorbance of these solutions was measured at about 
322 nm using UV/Vis. double-beam 
spectrophotometer. Cumulative percentage drug release 
was calculated using an equation obtained from a 
standard curve (Figure 1). 
 
 
Figure 1. Dissolution profile of different batches of 
tablets. 
 
Results and discussion 
Granules 
The granules prepared for compression of floating 
tablets were evaluated for their flow properties (Table 
2). Angle of repose was in the range of 24.512 to 
27.528 with granules containing methocel K100 and 
29.653 to 24.840 with methocel K15M. Bulk density 
ranged between 0.561 to 0.582 gm/cm3 with granules 
containing methocel K100 and 0.593 to 0.624 gm/cm3 
with methocel K15M. Tapped density ranged between 
0.634 to 0.680 gm/cm3 with granules containing 
methocel K100 and 0.667 to 0.692 gm/cm3 with 
methocel K15M. Carr index was found to be ranged 
between 0.089 to 0.154 and Hausner ratio ranged from 
1.098 to 1.182 for granules of different formulations. 
These values indicate that the prepared granules 
exhibited good flow properties. 
 
Floating tablets 
The floating tablets of Ranitidine HCL were prepared 
through effervescent technique by means of methocel 
(K100, K15M), sodium bicarbonate, citric acid and 
PVP K-30. The magnesium stearate was used as 
lubricant and talc was used as glidant. The results of 
the physicochemical characterization are given in table 
3. 
The weight of the tablet varied between 480.9 mg to 
486.6 mg for different formulations with low standard 
deviation values, indicating uniformity of weight. The 
variation in weight was within the range of ±4.5 
Khemariya et al. International Journal of Drug Delivery 2 (2010) 154-158 
 157
complying with pharmacopoeia specifications. The 
hardness for different formulations was found to be 
between 4.2. to 5.2 kg/cm2 indicating satisfactory 
mechanical strength. The friability was below 1% for 
all the formulations, which is an indication of good 
mechanical resistance of the tablet. The drug content 
varied between 119.20 – 119.79 mg in different tablets 






















B1 27.528±0.2350 0.561±0.032 0.634±0.043 1.130 0.115 
B 2 24.512±0.2900 0.567± 0.045 0.660 ±0.057 1.164 0.141 
B 3 27.210±0.3520 0.574± 0.058 0.652±0.083 1.135 0.119 
B 4 27.050±0.2520 0.582± 0.026 0.674±0.048 1.158 0.136 
B 5 24.625±0.3740 0.575± 0.048 0.680±0.061 1.182 0.154 
B 6 28.561±0.3800 0.624± 0.043 0.691±0.053 1.107 0.096 
B 7 24.840±0.972 0.624± 0.043 0.667±0.063 1.098 0.089 
B 8 29.653±0.784 0.605±0.086 0.682± 0.049 1.127 0.113 
B 9 28.462±0.8500 0.611±0.048 0.679 ± 0.057 1.111 0.100 
B 10 27.389±0.6740 0.593±0.053 0.692 ± 0.075 1.167 0.130 
 
 
All the tablets were prepared by effervescent technique. 
Sodium bicarbonate was added as a gas-generating 
agent. Sodium bicarbonate induced carbon dioxide 
generation in presence of dissolution medium (0.1 N 
hydrochloric acid).  
 
 
Table 3. Various tests data of ranitidine tablets. 
 













B1 484.2 ±0.19 0.59±0.02 4.2±0.21 39.85±0.15 33.25±1.96 10.26 
B2 483.3 ±0.25 0.59±.08 3.9±0.22 39.60±0.25 54.21±1.56 9.25 
B3 484.2 ±0.29 0.61±0.02 5.1±0.19 39.55±0.12 69.36±1.99 10.22 
B4 480.9 ±0.47 0.59±0.09 4.6±0.23 39.48±0.13 33.88±1.55 12.8 
B5 488.2 ±0.21 0.60±0.01 4.5±0.19 39.46±0.15 69.99±2.33 15.24 
B6 482.9 ±0.81 0.53±0.71 4.3±0.17 39.52±0.12 68.5±2.8 12.06 
B7 486.6 ±0.21 0.54±0.61 4.8±0.25 39.18±0.21 52.8±1.8 9.02 
B8 484.2 ±0.36 0.56±0.32 4.7±0.24 39.49±0.20 65.25±2.95 10.08 
B9 483.9 ±0.13 0.59±0.41 5.2±0.14 39.52±0.19 46.65±1.48 9.22 
B10 488.2 ±0.11 0.61±0.01 4.6±0.19 39.46±0.15 69.79±2.37 16.24 
 
 
The combination of sodium bicarbonate and citric acid 
provided desired floating ability and therefore this 
combination was selected for the formulation of the 
floating tablets. It was observed that the gas generated 
is trapped and protected within the gel, formed by 
hydration of polymer (methocel), thus decreasing the 
density of the tablet below 1 and tablet becomes 
buoyant. The tablet swelled radially and axially during 
in vitro buoyancy studies. 
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All the batches of tablets were found to exhibit shorter 
floating lag times due to presence of sodium 
bicarbonate and citric acid. Decrease in the citric acid 
level increased the floating lag time and tablets were 
found to float for longer duration. The tablets with low-
viscosity grade methocel K100 exhibited short floating 
lag time and floated for longer duration as compared 
with formulations containing high viscosity.Grade 
methocel K15M. This indicated that the molecular 
weight distribution or viscosity of the gel-forming. 
Polymer methocel influenced the in vitro 
buoyancy.The pH of the stomach (1-3) is elevated 
under fed condition (~3.8), therefore citric acid was 
incorporated in the formulation to provide an acidic 
medium for sodium bicarbonate; more over citric acid 
has an stabilizing effect ranitidine formulation. The 
effect of two different grades of methocel in the tablet 
with varying proportion of citric acid and sodium 
bicarbonate was studied on the release characteristics.It 
is evident from the in vitro dissolution data that 
increase in citric acid concentration increased the 
release rate but reduced the floating time, probably due 
to of excess carbon dioxide, disturbing the monolithic 
tablet. Formulations containing sodium bicarbonate and 
citric acid in ratio of 3:1 with varying amount of 
methocel were studied for their effect on release profile 
of ranitidine. It was observed that the release of 
ranitidine from such formulations increased on 
decreasing the proportion of methocel in the 
formulation but duration of floating decreased. The 
data obtained from in vitro dissolution studies and plot 
a graph time vs. % drug release. 
 
Conclusion 
The effervescent-based floating drug delivery system 
was a promising approach to achieve in vitro 
buoyancy. The addition of gel-forming polymer 
methocel with different grade and gas-generating agent 
such as sodium bicarbonate along with citric acid was 
essential to achieve in vitro buoyancy. The drug release 
from the tablets was sufficiently sustained and non- 
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